MHRA announces new recognition routes to facilitate safe access to new medicines with seven international partners

New regulatory recognition routes will be established using approvals from Australia, Canada, the EU, Japan, Switzerland, Singapore and the US. These mark the start of a new international recognition framework for medicines that will be in place by the first quarter of 2024.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news